SCHEMBL17481535

SCHEMBL17481535

OCCNCc1ccc(OCc2ccc(F)cc2F)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ PPARA Q07869 1/20 0.55
▸ MAOB P27338 1/20 0.53
▸ GSK3B P49841 2/20 0.52
▸ BACE1 P56817 2/20 0.52
▸ LMNA P02545 2/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ SCN3A Q9NY46 1/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ PDCD1 Q15116 1/20 0.46
▸ CD274 Q9NZQ7 1/20 0.46
▸ MME P08473 1/20 0.44
▸ ACE P12821 1/20 0.44
▸ CPA1 P15085 1/20 0.44
▸ ACE2 Q9BYF1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17481533 0.90 KMT2A (0.48) MEN1KMT2APPARAMAOBGSK3B
SCHEMBL17481411 0.88 PPARA (0.53) MEN1KMT2APPARAMAOBGSK3B
SCHEMBL17481414 0.86 PPARA (0.51) MEN1KMT2APPARAMAOBGSK3B
SCHEMBL17481532 0.85 KMT2A (0.55) MEN1KMT2APPARALMNANPSR1
SCHEMBL5514364 0.82 MAOB (0.62) MEN1KMT2APPARAMAOBGSK3B
SCHEMBL5020048 0.80 MAOB (0.61) PPARAMAOB
SCHEMBL2595400 0.78 ACHE (0.48) MEN1KMT2ASMN1; SMN2CD274USP28
SCHEMBL7024898 0.77 MAOB (0.68) PPARAMAOBGSK3BBACE1LMNA
SCHEMBL17611474 0.76 MAOB (0.59) PPARAMAOBGSK3BBACE1NPSR1
SCHEMBL5511238 0.76 MAOB (0.58) PPARAMAOBGSK3BBACE1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160031799-A1 P62-ZZ CHEMICAL INHIBITOR ID4PHARMA LLC (US) 2016-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031799-A1 P62-ZZ CHEMICAL INHIBITOR SQSTM1, CTSZ, BECN1 MEN1 1167/4885KMT2A 756/4885PPARA 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback